Research involving biological material from forensic autopsies: legal and ethical issues by Elger, Bernice S. et al.
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
 Original Paper 
 Pathobiology 2009;76:1–10 
 DOI: 10.1159/000178150 
 Research Involving Biological
Material from Forensic Autopsies:
Legal and Ethical Issues 
 Bernice S. Elger a    Marie-Claude Hofner b    Patrice Mangin a, b  
 University Center of Legal Medicine of Geneva and Lausanne, Universities of  a  Geneva and  b  Lausanne , Switzerland
 
the autopsy and related analyses, which might include
genetic testing. In order to be allowed to carry out future 
research projects, families need to be approached for
informed consent, unless the deceased person had left
written directives including permission to use his or her tis-
sues for research.  Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 The use of human biological tissue for research is a 
controversial subject, especially if tissue samples have 
originally been taken and stored for other reasons, for 
example clinical purposes  [1] . Collections of biological 
material obtained for clinical or research purposes are 
often referred to as ‘biobanks’  [1] . Such collections are 
found predominantly in pathology institutions, but exist 
also in most university hospitals as well as in private in-
stitutions. Population biobanks are being established in 
various countries  [2–4] . In order to clarify controversial 
ethical and legal issues, several countries, including the 
UK  [5] , Sweden and Estonia, have passed laws regarding 
the use of biobanks for research  [6] , but many countries 
have not. Some countries, for example Switzerland, have 
law projects  [7] . In several countries, including France, 
Canada and the USA, national bioethics advisory com-
mittees have issued reports and recommendations  [8–10] . 
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 Abstract 
 Recommendations and laws do not always contain specific 
and clear provisions on the use of cadaveric material in re-
search, and even more rarely do they address explicitly the 
ethical issues related to research on material obtained dur-
ing forensic autopsy. In this article we analyse existing legal 
frameworks in Europe by comparing the legal provisions in 
2 European Countries which are member states of the Coun-
cil of Europe, the UK and Switzerland. They were chosen be-
cause they have distinct legal frameworks that make com-
parisons interesting. In addition, the detailed laws of the UK 
and a specific law project and national ethical recommen-
dations in Switzerland permit us to define more clearly the 
legal range of options for researchers using cadaveric mate-
rial obtained during forensic investigations. The Human Tis-
sue Act 2004 in England, Wales and Northern Ireland, its 
Scottish equivalent with the same title (2006) and the na-
tional ethical guidelines in Switzerland all require consent 
from the deceased person, an appropriate relative or a per-
son with power of attorney for healthcare decisions before 
cadaveric biological material can be obtained and used for 
research. However, if the purpose of the autopsy is purely 
forensic, no such authorisation will be sought to carry out 
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International guidance is provided by the Council of Eu-
rope in its recent recommendation on research on bio-
logical materials of human origin  [11] . Most guidelines 
and laws apply to collections of human biological mate-
rial in general and some include particular, additional, 
regulations for population biobanks. These additional 
measures are mostly reinforced oversight mechanisms 
such as audits and/or registers  [7, 11] .
 These European recommendations and laws address 
ethical issues related to material obtained from donors in 
general. They do not always contain specific and clear 
provisions on the research use of cadaveric material. Even 
more rarely do they address explicitly the ethical issues 
related to research on biological material obtained during 
forensic autopsy.
 Whereas the legal and ethical problems of research in-
volving material stored by non-forensic pathologists are 
being discussed in a growing number of publications  [5, 
12] , the implications of recent legal and policy develop-
ments on research in the forensic context has only very 
rarely been addressed  [13] . The aim of this article is to fill 
this gap. It will pay special attention to regulatory issues 
concerning research involving cadaveric tissue obtained 
during forensic investigation.
 The article has 3 parts. First, we will provide an over-
view of the general ethical and legal principles that guide 
research involving biobanks in Europe, which follow re-
cent recommendations from the Council of Europe and 
legislation, especially from the UK and Switzerland. We 
will focus on issues that are relevant for research by fo-
rensic and other pathologists.
 Second, we will analyse in more detail the existing le-
gal provisions in 2 European countries that are members 
of the Council of Europe, the UK and Switzerland. They 
were chosen because they have distinct legal frameworks 
that make comparisons interesting. In addition, the de-
tailed laws of the UK and a specific law project and na-
tional ethical recommendations in Switzerland permit us 
to define more clearly the legal range of options for re-
searchers using cadaveric material obtained during fo-
rensic investigations.
 We will identify and examine legal provisions address-
ing explicitly research involving cadaveric tissue obtained 
during forensic investigation. Where such provisions are 
lacking, we will discuss whether and how more general 
provisions for research involving other kinds of human 
tissue apply to the forensic context.
 Third, we will not only examine the theoretical legal 
framework, but also consider the specific practical and 
ethical problems faced by researchers, pathologists and 
research ethics committees (RECs) that arise in the fo-
rensic context under these specific legal frameworks. 
 The aim of this discussion of existing ethical guide-
lines, ethical arguments and practical problems is to help 
forensic pathologists choose the most acceptable ap-
proach when planning prospective research on cadaveric 
material obtained during forensic autopsies.
 Research Involving Biobanks in Europe:
General Ethical and Legal Principles 
 The recent public attention to the ethical use of human 
biological material  [14, 15] has caused changes that are 
important for the way in which pathologists in general 
and forensic pathologists in particular store and use hu-
man biological material. These changes are especially im-
portant in the area of obtaining consent.
 Consent to Research Involving Tissues 
 The Council of Europe has affirmed repeatedly that if 
biological material is obtained for research, ‘consent or 
authorisation to obtain such materials should be as spe-
cific as possible with regard  to any foreseen research uses’ 
 [11, 16] . Biobanks are particularly affected by the issue of 
consent to secondary uses. Tissue collections established 
by pathologists working in a clinical and/or forensic con-
text, and biobanks obtained primarily for a defined type 
of research are relevant examples concerning the coun-
cil’s statement about secondary uses. All these different 
types of tissue collections might be useful for future re-
search, including types of research that were unknown at 
the time when the material was collected.
 Briefly, the legal and ethical principles concerning re-
search on material from living or dead donors require 
investigators to routinely obtain separate consent for 
 research, either from donors or – if the donor is de-
ceased – from their family, and to make an effort to ob-
tain both specific consent for defined research projects 
and broader consent for future studies. 
 Waivers of Consent 
 It is rare for exceptions to be made that authorise re-
search without the relevant consent. Legislations do, in 
general, provide for certain explicit exceptions. For ex-
ample, in the UK these include storage and use of tissue 
that has been removed from a living person for education 
and training  [17] . This is not the case in Switzerland, 
where national guidelines require similar consent for ed-
ucation and training as for research  [18] .
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 The Council of Europe permits an exception for con-
sent to research involving so-called ‘residual material’. Ar-
ticle 22 of the recommendations states that ‘if the proposed 
use of identifiable [residual] biological materials in a re-
search project is not within the scope of prior consent, if 
any, given by the person concerned, reasonable efforts 
should be made to contact the person in order to obtain 
consent to the proposed use’. If, in spite of reasonable ef-
forts, it is not possible to contact the person concerned, 
‘these biological materials should only be used in the re-
search project subject to independent evaluation of the 
fulfilment of the following conditions: (a) the research ad-
dresses an important scientific interest; (b) the aims of the 
research could not reasonably be achieved using biological 
materials for which consent can be obtained; and (c) there 
is no evidence that the person concerned has expressly op-
posed such research use’. However, the Council of Europe 
makes clear that these exceptions for residual biological 
materials ‘removed for purposes other than storage for 
 research’ should not become routine practice. Indeed, ar-
ticle 12 clearly states: ‘Whenever possible, information 
should be given and consent or authorisation [for research] 
requested before biological materials are removed.’
 The recommendations from the Council of Europe, as 
well as legislation in a number of European countries, 
contain another notable exception. Secondary research 
use without consent is permitted on biological material 
obtained with consent for a primary purpose, if the mate-
rial is irreversibly anonymised, also called ‘unlinked ano-
nymised’. Irreversible anonymisation means that it is not 
possible to link the tissue and associated information to 
data permitting the identification of the tissue donor. Leg-
islation in some countries extends this exception to re-
versibly anonymised, also called ‘linked anonymised’, tis-
sue and information. In this case, identification of the do-
nor is possible via a code, but the users of the material do 
not have access to this code. In line with this concept, in 
the USA, consent is not required if non-anonymised ma-
terial contained in a biobank is given out to researchers in 
a way that does not permit them to identify the donor  [19, 
20] . In the UK, this exception was introduced as an amend-
ment to the Human Tissue Act 2004 during the bill’s pas-
sage through Parliament, after researchers expressed their 
fears that the new Act would severely restrict research. 
This amendment permits the use and storage of tissue 
without consent under the condition that the tissue is an-
onymised and that the research study has been approved 
by a research ethics committee (s1, 7–9 of the Act  [17] ).
 Switzerland is currently discussing a new law project 
on human subject research which includes research on 
tissue. This Swiss federal law project provides an interest-
ing consent waiver, which is limited to cadaveric tissue, 
and foresees the possibility for research on cadaveric tis-
sue without consent of the deceased persons or their rela-
tives under particular circumstances. According to the 
Swiss law project, it is permissible to use biological mate-
rial obtained from an autopsy for research without con-
sent  [7] if the samples are anonymised, if the quantity of 
material used is minimal and if there is no document at-
testing the refusal of the deceased person. All conditions 
need to be fulfilled simultaneously. Minimal quantity is 
defined in the official commentary to the law  [21] as 
meaning any quantity the lack of which does not represent 
an additional harm to the corpse. It must therefore be a 
very small quantity. Obtaining any macroscopic part or 
entire organ or doing any other type of research involving 
a deceased person or body parts is considered an addi-
tional harm. This type of research must be covered by the 
consent obtained from the individual before death or fur-
ther consent must be obtained from the next-of-kin or a 
therapeutic representative chosen by the deceased. The 
next-of-kin according to Swiss jurisdiction is the person 
who had the closest relationship with the deceased person 
immediately before this person died.   In the UK, the next-
of-kin are ranked, ranging from spouse or partner over 
parent or child to longstanding friends, and in Switzer-
land a change of the civil law is under discussion which 
might introduce a similar ranking. At present, this rank-
ing has already been introduced by application law (or-
donnance) to the Swiss transplantation law from 2007.
 It remains to be seen whether and to what extent the 
different consent waivers will be used in the future, espe-
cially for long-term collection and storage of tissue for use 
in large tissue banks. As the next section will show, it is 
not clear whether and under which conditions waivers 
would be accepted by RECs. For most types of tissue 
banks ‘obtaining consent is likely to be regarded best 
practice for long-term storage and use’  [17] .
 Consent and the Role of Research Ethics Committees 
 It should also be noted that a considerable number of 
details defining ‘appropriate’ consent will be left to the 
judgement of individual RECs. Legal provisions define a 
rather broad framework, and they do not offer special 
guidance to RECs on how to judge specific details of a 
given research protocol. Indeed, RECs are bound by the 
legal provisions, but could add even stricter ethical re-
quirements before approving a particular study. 
 It is well known that research involving biological 
samples stirs controversy especially if genetic testing is 
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part of the project. A few years ago, researchers in the UK 
encountered variations in the ethical standards of local 
RECs concerning a multi-centre study involving genetic 
testing of samples obtained from people who died from 
sudden arrythmic death syndrome  [22] . Meanwhile, a 
new ethics approval mechanism has been created for tis-
sue banks in the UK  [5] . It offers the possibility to tissue 
banks to obtain a sort of general approval that includes 
operating the bank, obtaining samples according to an 
approved protocol, and giving out tissue to researchers. 
For research that is within the scope of the biobank’s ap-
proved range of projects, researchers do not need to re-
quest ethics approval themselves. This simplified approv-
al mechanism could be useful if special collections of tis-
sue were established by forensic or other pathologists, but 
would not automatically apply to research involving con-
secutive single autopsy cases related to sudden death. 
These would need regular REC approval, especially if ge-
netic testing is involved. Researchers have complained 
that RECs apply unnecessarily strict rules. The risk exists 
that RECs refuse protocols mainly as an overreaction to 
the highly emotionalized debate about the use of tissue in 
order to ‘be on the safe side’  [23, 24] .
 Broad versus Narrow Consent  
 The scope of consent is a notorious reason for contro-
versy in the ethical and legal debate about biobanks. In 
both the UK and in Switzerland, it is best practice to ask 
for specific informed consent if a particular research 
project is already defined. The typical problem of re-
search involving stored biological material is that the de-
tails of future research projects are not yet known. How-
ever, it is difficult if not impossible to obtain new in-
formed consent for each new research project. Should 
broad consent that does not imply detailed information 
about future research projects be valid for stored mate-
rial? While professional organisations such as the Euro-
pean Society of Human Genetics  [25] or the College of 
American Pathologists  [26] and national guidelines from 
several countries  [18, 19, 27] claim that broad forms of 
consent are acceptable, there is strong resistance to aban-
doning the classic type of specific informed consent, es-
pecially in the USA  [19] .
 In the UK, broad consent is used in the UK biobank 
project that has been enrolling participants since Febru-
ary 2007  [28, 29] . Broad consent for research is allowed to 
some extent in the UK by its new legal provisions and it 
is implied that such consent may be long lasting  [5] . Broad 
consent is also permissible according to ethical recom-
mendations. Indeed, the UK Medical Research Council 
(MRC) approves it under certain conditions. The MRC 
guidelines  [30] combine elements of broad and specific 
consent within a 2-layered consent. Concerning cadav-
eric material, the wishes of the deceased person have to 
be taken into account in the first place. According to ar-
ticle 11.1, ‘before removing and retaining human mate-
rial for research at a post-mortem examination, all rea-
sonable steps must be taken to ascertain that the deceased 
would not have objected (for example, for religious rea-
sons)’  [30] . If no reason exists to believe that the deceased 
person has objected, informed consent from the next-of-
kin must be obtained. Consent to storage has to be as 
specific as possible. The article continues: ‘The person 
asked to give consent should be given clear information 
about what tissue/organ will be retained, who will be cus-
todian, how long the sample will be kept, what types of 
research it may be used for and how it will be disposed of 
when no longer required.’ Although the MRC opposes 
blanket consent, which is described as ‘unconditional’ 
consent to ‘all biological or medical research’, it allows for 
some form of broad consent in form of a ‘2-part’ consent 
[p. 15 in  30 ]. First, specific consent is given to an already 
defined research project and then a broader consent to 
other future studies is added. The MRC is aware that fu-
ture research is partly or totally ‘unforeseen’. This contra-
dicts the idea of providing detailed information at the 
beginning. The guidelines seem to permit future research 
to be carried out without new specific consent, if the proj-
ect is approved by an ethics committee and if the results 
will not have direct clinical implications for the deceased 
individuals or their family members. 
 In article 11.1 the MRC recommends specific precau-
tions if biological material will be used for genetic testing. 
While in the case of removal of samples from a deceased 
person there is clearly no possibility of physically harm-
ing the person from whom the material is obtained, ‘some 
research results (e.g. from genetic studies) may have im-
plications for the surviving family members. The poten-
tial implications for relatives of any research to be done 
using linked [identifiable] samples must be discussed, 
and they [relatives] must be given the opportunity to 
learn about any research results that might impact on 
their interests’  [30] . Among the proposed safeguards is 
the possibility to withdraw consent, which is mentioned 
in the MRC’s example of a consent form [p. 33 in  30 ]. The 
consent form contains the wording: ‘I agree … that I am 
free to withdraw my approval for use of the sample at any 
time without giving a reason.’ As explained by the MRC, 
withdrawal of consent is of ethical importance with re-
spect to cadaveric material since the consent of family 
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members ‘is being sought at a particularly stressful time’. 
Hence, ‘relatives should wherever possible, be given time 
to reflect before making their decision, and it is particu-
larly important that written information is provided for 
later reference. Contact details of the research team must 
be provided in case relatives have further questions or 
change their minds later’  [30] .
 Finally, it is of interest to know that the main request 
from patients and families is to be informed about organs 
and tissue being retained for research. The majority of 
them find broad and long-lasting consent acceptable  [15, 
31, 32] .
 In Switzerland, for the time being the guidelines of the 
Swiss Academy of Medical Sciences (SAMS) authorise 
broad consent. Article 4.3 of these guidelines states: ‘Con-
sent can generally also cover the further use of the sam-
ples and data for future research projects (general con-
sent).’ This broad consent is appropriate for all types of 
research which do not involve special risks for donors and 
in which reversibly or irreversibly anonymised samples 
are used. ‘The donor must however expressly give his 
consent to a research project’ if ‘this envisages research 
with non-anonymised samples’  [18] . In the case of cadav-
eric biological material, it is difficult to imagine ‘special 
risks for donors’, unless one takes into account risks re-
lated to the violation of confidentiality. Indeed, the dig-
nity of deceased donors might be affected if they are 
found to test positive for stigmatising diseases, such as 
HIV, other sexually transmitted diseases or perhaps some 
genetic disorders. Ethical problems of research involving 
genetic testing of cadaveric material are related less to the 
risks to the deceased individual than they are to concern 
for the consequences for family members. These people 
have a right to know and a right not to know. Both can be 
respected if broad consent to research with autopsy mate-
rial is obtained from close relatives.
 Although the Swiss guidelines allow for restriction of 
the use of the tissue to one specific field of research  [18] , 
it is advisable for researchers to keep the consent as 
broad as possible and to include consent to genetic test-
ing. Several RECs have so far accepted forms of broad 
consent for biobanks in Switzerland: examples are the 
tumour bank in Berne  [33] and the Swiss national pae-
diatric tumour bank in Zurich  [34] . In both biobanks 
genetic testing is permitted. The information leaflet 
provided states that sample donors have the right to re-
fuse feedback about the research results, thereby re-
specting both their right to know and not to know. If 
research participants do not refuse feedback, the bio-
banks will inform the donor’s treating physician of any 
results that are important for the health of the person 
who provided the samples.
 Swiss guidelines, like most guidelines that favour 
broad consent, admit that those who consented should 
have the right to opt out of future projects  [18, 25, 27, 
30] .
 Research on Cadaveric Material Obtained during 
Forensic Investigation 
 Recommendations from the Council of Europe 
 In the following we examine legal provisions that ap-
ply in the forensic context. Where specific legislation is 
lacking, we refer to more general provisions and interpret 
their meaning for the forensic pathologist. The specific-
ity of the forensic context is that autopsies and storage of 
material are carried out without family consent at the re-
quest of a judicial authority. Forensic pathologists are not 
routinely in contact with the family of the deceased per-
son. Indeed, forensic pathologists remove, store and anal-
yse cadaveric human biological material at the request of 
a judicial authority, such as a coroner  [35] in England, 
Wales and Northern Ireland  [13, 36] , a procurator fiscal 
in Scotland  [13, 37] or the examining magistrate in Swit-
zerland. The stored material might be useful for research 
after the legal procedure – in general, a death investiga-
tion – has come to an end.
 The recommendations from the Council of Europe do 
not contain an explicit section on research on cadaveric 
material obtained in a forensic context. Therefore, foren-
sic pathologists must refer to recommendations on the 
use of cadaveric material in general. The exact meaning 
of this section, however, is open to interpretation. Article 
13 of the recommendations states only: ‘Biological mate-
rials should not be removed from the body of a deceased 
person for research activities without appropriate con-
sent or authorisation.’ It is not further defined which con-
sent or authorisation procedures are appropriate, except 
that any of these procedures will be invalidated if the de-
ceased person is known to have objected to research ac-
tivities. In this case, biological materials should not be 
‘removed or supplied’ for any type of research  [11] .
 UK and Swiss Legal Frameworks concerning Forensic 
Biological Material 
 Since special guidance from the Council of Europe is 
lacking, it is useful to also examine legislation in coun-
tries that are members of the Council of Europe. Recent 
new legal provisions in some countries, such as the Hu-
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man Tissue Act 2004 in the UK, might help to clarify the 
limits within which forensic pathologists will be allowed 
to carry out research on cadaveric tissue. The UK has re-
cently enacted 2 tissue acts, one applying to England, 
Wales and Northern Ireland and the other to Scotland. If 
a person in the UK dies from suspicious, unnatural or 
unknown causes, the judicial and forensic evaluation 
takes place under the authority of a coroner (in England, 
Wales and Northern Ireland) or a procurator fiscal (Scot-
land). Since Scotland and the rest of the UK have recent-
ly enacted different new tissue legislation, forensic autop-
sies do not follow exactly the same rules. This could cre-
ate problems for national research endeavours and other 
types of collaboration  [13, 38] . In the past, forensic pa-
thologists were obliged to store any material that might, 
according to their knowledge, be useful to determine the 
cause of death. The length of storage was determined by 
the coroner for each case. It was not clear whether the 
coroner was authorised to request ongoing storage after 
the end of the legal investigation. In addition, coroners 
were under no obligation to inform relatives of the de-
ceased person about the storage of the tissue. The new 
amended rules from 2005  [36] try to fill the gap and de-
fine further obligations. First, UK pathologists outside 
Scotland must provide detailed information to the coro-
ner about the stored material. Second, the next-of-kin has 
to be able to decide between donation for research or de-
struction of the material. The next-of-kin of an adult is 
defined by article 3.6c in the Human Tissue Act  [35] as 
the ‘person who stood in a qualifying relationship to him 
immediately before he died’. Qualifying relationships are 
defined in section 3.6c and, according to the Act, should 
be ranked in a given order ranging from spouse or part-
ner, parent or child, brother or sister to a friend of long-
standing (article 27.4). When the authority of a coroner 
ends at the conclusion of the investigation, material can 
only continue to be stored with appropriate consent, for 
example from donors or relatives, as defined by the Hu-
man Tissue Act  [35] .
 The situation is different in Scotland, at least concern-
ing small quantities of material. Entire organs can be 
stored only with the consent of the appropriate relatives 
once the legal investigation has come to an end. However, 
tissue blocks and slides can be lawfully stored after the 
procurator fiscal has closed the investigation. The use of 
these tissue blocks and slides is restricted to diagnostic 
review and audit. Any other use, for example for research 
or education, is authorised only with the appropriate con-
sent  [13] .
 Switzerland is composed of 26 cantons, and distinct 
cantonal laws exist in each of them. At present, in some 
regions, cantonal law restricts the use of forensic tissue 
beyond the requirements found in national or federal rec-
ommendations. In order not to overly complicate the 
comparison, we will limit the analysis of the Swiss legal 
basis to national recommendations and forthcoming fed-
eral law which will, if enacted, in principle overrule can-
tonal dispositions. Since the Swiss law on research involv-
ing human subjects and human tissue has not yet come 
into force, presently the use of human biological material 
for research is guided by national recommendations from 
the SAMS  [18] , which are of legal value according to a de-
cision from the federal supreme court. The SAMS guide-
lines refer specifically to the use of cadaveric material ob-
tained during forensic investigation (in part III). This 
part discusses tissue collections established by forensic 
pathologists: ‘Parts of cadavers that were obtained and 
preserved in the course of investigations carried out ac-
cording to criminal law or by other authorities may be 
kept in special collections after expiry of the storage time 
required for legal reasons and with the consent of the au-
thorities ordering these measures, provided there are sci-
entific reasons and reasons of education and general in-
terest for doing so. In this respect, any objections to 
storage of the preparations on the part of close relatives 
must be taken into account.’
 Since part III relates to ‘special collections’ only, foren-
sic pathologists should also be aware of a second part of 
the guidelines which concerns the prospective use of ma-
terial from deceased persons in general: ‘If material is re-
moved from a deceased person (e.g. in the course of an 
autopsy), that person’s prior consent to the storage and 
further use of this material for the purposes of research 
is necessary (patient’s prior instructions). If the deceased 
person had not given consent, the closest relatives may 
give their consent, provided this is not in contradiction 
of the deceased’s wishes expressed or presumed during 
his lifetime’ (part 4.5)  [18] .
 Whereas in the second quotation consent of relatives 
to research is obligatory, although overridden by any pre-
sumed refusal of the deceased person, the quotation relat-
ing to forensic medicine (part III) is somewhat more am-
biguous since it does not explicitly use the term ‘consent’, 
but refers only to ‘any objections’ on the part of close rel-
atives. Part III could be interpreted to mean a form of 
presumed consent, putting the burden of manifesting ob-
jection on relatives. This could imply that forensic pa-
thologists are under no obligation to contact relatives in 
all cases, as long as they have obtained permission from 
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the judicial authorities who authorised tissue removal in 
the first place. However, the provisions described in part 
III seem to provide mainly an authorisation for storage 
and not for specific research projects. For specific re-
search projects, the stricter requirements of part 4.5 are 
likely to be regarded as best practice and will probably 
need to be followed.
 The federal law project provides the possibility for re-
search on cadaveric tissue without consent of the de-
ceased persons or their relatives under the circumstances 
discussed above (anonymity, small quantity, no objection 
of the donor).
 Putting Law into Practice: Legal and Ethical Issues 
concerning Research with Human Material from 
Forensic Autopsies 
 As the preceding parts show, the legal context in both 
countries concerning research involving forensic biolog-
ical material is not very detailed and leaves a number of 
questions open. In the following part we will discuss in 
more detail the main ethical, legal and practical issues a 
forensic pathologist has to face regarding this research. 
For each issue it is important to put the legal texts into the 
broader ethical context.
 The local legal basis, as described above, provides a 
framework that must not be transgressed. Within this 
legal framework, a range of options exist. These options 
have to be carefully evaluated with respect to details that 
make them more or less ethically acceptable. Existing 
professional and national ethical guidelines, as well as the 
balancing of ethical principles and ethical arguments, 
help to identify the most appropriate approach. In the fol-
lowing we will discuss different options to the forensic 
pathologist concerning consent to storage and research.
 Consent to the Storage of Biological Material: 
Recommendations That Apply to Forensic 
Pathologists Similarly as to Other Researchers 
 Forensic pathologists, like their colleagues outside fo-
rensics, cannot ignore the changes due to recent public 
attention which has brought about new legal frameworks 
and ethical recommendations concerning the use of hu-
man biological material. New regulations concern the 
storage of human biological material. As the above sum-
mary of new laws and recommendations has shown, past 
practice for storing material beyond the end of forensic 
investigations is no longer permitted in most parts of 
Switzerland and the UK (except Scotland where the stor-
age of small quantities of material for clinical purposes is 
allowed  [13] ). Since the material is scientifically valuable, 
forensic pathologists have an ethical obligation to plan 
for legally acceptable forms of storage ahead of time.
 It is important for pathologists and forensic patholo-
gists to be aware of the more general ethical and legal is-
sues, as well as recent specific guidelines and laws. Con-
sent to storage and a specific research project should be 
distinguished from broad consent to future studies. Dif-
ferent forms of valid consent to future research exist and 
it is useful not to unnecessarily restrict further uses of the 
biological material by a type of consent that is narrower 
than legally or ethically required. 
 Therefore, for forensic pathologist it is advised to use 
always a ‘2-part’ consent from relatives of autopsied vic-
tims, as has been explained above. In addition to the spe-
cific consent to the defined project, broad consent to fu-
ture research projects should be obtained. This broad 
consent is ethically acceptable not only for research in 
institutes of non-forensic pathology, but also in the foren-
sic context. It does not represent an abuse of the confi-
dence of those who consent, if all future research projects 
need approval of a research ethics committee, as recom-
mended by the MRC and is the case, for example, in Ge-
neva. The REC will judge if the broad consent is sufficient 
in light of the risks involved in a future individual re-
search project on tissues. For some particularly sensitive 
projects involving genetic testing, the REC might require 
specific consent and oblige researchers to contact family 
members for new consent. 
 In addition, forensic pathologists should grant those 
who consented the right to opt out of future projects, as 
included in most guidelines that favour broad consent 
 [18, 25, 27, 30] .
 Research without consent on samples stemming from 
forensic autopsies will be possible if the text of the Swiss 
law project is maintained and the law comes into force in 
3 or 4 years. As stated above, according to the permissive 
approach defined by the present law project, cadaveric 
tissue within, but also outside, the forensic context can be 
used without consent of the deceased persons or their 
relatives if 3 conditions are fulfilled simultaneously: the 
samples are anonymised; the quantity of material used is 
minimal, and there is no document attesting the refusal 
of the deceased person  [7] . This would permit a number 
of types of research at the histological or microscopic lev-
el and relieve the forensic pathologist of the burden of 
obtaining consent from grieving relatives. It is, however, 
not clear whether genetic testing without consent is al-
lowed within the scope of this law project. Since forensic 
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pathologists examine typically cases of sudden deaths 
where genetic testing might be indicated  [39, 40] , they 
will still have to rely on consent from relatives for re-
search even if the law project comes into force. In addi-
tion, even if the law did not require consent from the de-
ceased persons or their relatives, this does not remove the 
need for REC approval of research projects involving ge-
netic testing. The REC will evaluate whether the genetic 
tests might have any consequences for the health or life 
of the deceased person’s family members. In this case, 
feedback of research results to the relatives could be indi-
cated  [41, 42] . In addition, research on completely ano-
nymised samples could be judged inappropriate in this 
situation and the REC could require that consent of fam-
ily members should be sought.
 Specifics to the Forensic Context and Ethically 
Relevant Practical Problems 
 Storage of Particular Types of Forensic Biological 
Material 
As discussed above, presently the SAMS guidelines 
contain a somewhat ambiguous statement indicating that 
the storage of samples obtained during forensic autop-
sies – albeit probably not all types of research – could be 
authorised with some form of presumed consent (part III 
 [18] ). This exception is presently explicitly limited to fo-
rensic collections and does not apply for other types of 
biological material. The exact characteristics of forensic 
tissue collections that fall under this particular exception 
are not defined, other than the condition that scientific 
reasons, reasons of education or a general interest must 
exist.
 Permission from Judicial Authorities 
It is important to routinely obtain appropriate permis-
sion from judicial authorities for further storage and re-
utilisation for research of the biological material, espe-
cially since the administrative burden is minimal and the 
request is in most cases not more than a formality. In-
deed, as the MRC in the UK points out, the coroner (or 
procurator fiscal in Scotland) can prohibit research, even 
if consent has been obtained from a relative. ‘Therefore 
the coroner or procurator fiscal must be consulted before 
tissue is retained for research’ [section 11.2 in  30 ].
 On the other hand, the MRC states that the judicial 
authority (coroner, judge, etc.) ‘cannot authorise the re-
tention of tissue for research’, even following autopsies 
required by law because consent of the deceased person 
or his/her relatives is required. The legally valid and eth-
ically most appropriate practice is, therefore, to envision 
routinely consent of relatives to storage and to future re-
search during or around the end of the forensic investiga-
tion when it is still possible to make contact with the rel-
atives through the judicial authority.
 However, obtaining consent from family members 
implies practical problems and many of these problems 
are ethically relevant. When planning consent proce-
dures, it is important to pay attention to the way in which 
consent is obtained (by whom and when) and to the type 
of consent used.
 Practical and Ethical Problems of Routine Consent 
in Forensic Pathology 
The Human Tissue Act 2004 in England, Wales and 
Northern Ireland, its Scottish counterpart (2006) and the 
national ethical guidelines in Switzerland require con-
sent either of the deceased person or of an appropriate 
relative or therapeutic representative, before cadaveric 
biological material can be obtained and used for research  
 (although the Scottish Act uses the term ‘authorisation’ 
instead of consent, the concept seems to be the same 
 [5] ).
 However, if the purpose of the autopsy is purely foren-
sic, no authorisation will be obtained from the family to 
carry out the autopsy and related analyses, which might 
include genetic testing. Families must be approached for 
informed consent to future research projects unless the 
deceased person had left written directives including per-
mission to use his or her tissue for research. At present, 
such a living will is a rare occurrence. 
 The definition of the appropriate next-of-kin varies in 
different jurisdictions and is not the same in the UK and 
Switzerland, as shown above. Obtaining next-of-kin con-
sent for research use of tissue obtained during forensic 
autopsy is ethically and practically daunting. The foren-
sic pathologist has access to the family only through the 
judicial authority, and only the coroner or examining 
magistrate in charge of the case can authorise such con-
tact and provide the addresses. In some cases of sudden, 
unexpected deaths outside hospital, it might not be easy 
or possible to identify relatives, especially if the death has 
occurred at great distance from the place where the de-
ceased person lived. 
 It is open to debate who should contact the next-of-kin 
in order to obtain consent for research involving tissue 
obtained after forensic autopsies  [43] . The person to make 
contact could be from the office of the judicial authority 
in charge of the case, the forensic pathologist, the re-
searcher (who could be a geneticist) or a third party. Who 
carries out the task has an ethical dimension because it 
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could affect the quality of the information provided to 
the person who has to give consent and it might influence 
significantly the rate of agreement to research. Physicians 
trained in forensic medicine have, in general, sufficient 
experience to interact with relatives of a deceased person. 
However, the person who obtains informed consent 
should also have sufficient time and understanding of the 
research project to discuss it with the relatives. If the con-
tacting forensic physician/pathologist is not actively tak-
ing part in the research project, then it is unlikely that 
this would be the case.
 Another point to consider is that consent to research 
must be both freely given and informed. Since the foren-
sic autopsy is ordered by a judicial authority, the relative 
approached might feel under pressure to consent to re-
search, especially if the family is contacted by a person 
involved in the legal procedure and the forensic investiga-
tion. In this context one must also consider the possibil-
ity that consent is refused if the next-of-kin who has to 
provide consent was involved in the death, suspects a 
family member to be involved whom he or she wants to 
protect, or feels guilty for some (even irrational) reason. 
In these cases the next-of-kin might wish to make sure 
that no further investigation is possible and ask for de-
struction of all material.
 On the other hand, geneticists, other researchers or 
third parties are not familiar with legal issues related to 
forensic autopsies and lack experience with bereaved rel-
atives in this context.
 A more general problem is when to contact the family. 
A study in the UK showed  [22] that several families were 
too grief-stricken to agree to their own participation in a 
study involving cardiac assessment. It is unclear whether 
they would consent to research involving tissue from the 
deceased person. In this context, the principal questions 
to be answered are whether it is justified to assume that 
family members will be able to provide free and informed 
consent in emotionally difficult situations such as the 
death of a close relative, and whether it is ethically appro-
priate to approach families systematically. However, if the 
benefit for other patients or for society is important, as is 
the case for the procurement of organs for transplanta-
tion or for certain types of research with severely ill inca-
pacitated patients, ethics committees have considered in 
the past that it is justified to approach grief-stricken fam-
ilies for consent. Sufficient reasons exist to indicate that 
it is ethically appropriate to ask family members for con-
sent to future research use of biological material taken 
from a deceased relative. Unlike in the situation of a re-
trieval of organs for transplantation, in the forensic set-
ting families can be approached several weeks or months 
after the death of their relative for those biological mate-
rials that have been stored legally until then because stor-
age was part of the forensic investigation. In light of the 
scientific value of the material, the stress imposed on 
families at a greater distance in time from their acute 
grief does not seem disproportional. In addition, some 
families could even be relieved that some tissue or DNA 
of their deceased relative could be of benefit and help to 
further scientific knowledge and public health.
 Conclusions 
 Although the legal frameworks regulating prospective 
research on autopsy samples in the UK and in Switzer-
land are presently different, some basic requirements are 
alike. In addition, national guidelines from both coun-
tries contain many analogous argumentations and con-
clusions. As a consequence, the recommended approach 
for forensic pathologists is similar in the UK and Switzer-
land. Indeed, the aim is not only to stay within the limits 
of the law, but also to choose the most ethical approach. 
The main elements of this approach are to routinely ob-
tain: (1) authorisation from competent judicial authori-
ties for storage and research use, and (2) broad consent 
from the appropriate next-of-kin, unless consent to stor-
age and research has already been provided by the de-
ceased person prior to death. Relatives should be ap-
proached, if possible, at a time after their period of acute 
grief, and the consent form should explicitly mention ge-
netic testing. If a specific research project is defined at the 
time of the consent, in addition to broad consent to future 
research projects, specific informed consent to this proj-
ect is required. REC approval should be obtained for fu-
ture research projects on samples that have been stored 
with broad consent from relatives, and those who provide 
consent should be informed about their right to withdraw 
consent in the future.
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